Skip to main content

A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies



Validation of novel multiplex technologies

Author(s): Levent Akyüz*, Andreas Wilhelm, Florian Butke, Park Su-Jin, Anja Kuckuck, Hans-Dieter Volk, Gerald Grütz
Published in: Advances in precision medicine, Issue bi-annual, 2017, ISSN 2424-9106

PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial

Author(s): Lars Norgren, Norbert Weiss, Sigrid Nikol, Robert J. Hinchliffe, John C. Lantis, Manesh R. Patel, Holger Reinecke, Racheli Ofir, Yael Rosen, Dan Peres, Zami Aberman
Published in: European Journal of Vascular and Endovascular Surgery, Issue 57/4, 2019, Page(s) 538-545, ISSN 1078-5884
DOI: 10.1016/j.ejvs.2018.11.008

Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry

Author(s): Chotima Böttcher, Stephan Schlickeiser, Marjolein A. M. Sneeboer, Desiree Kunkel, Anniki Knop, Evdokia Paza, Pawel Fidzinski, Larissa Kraus, Gijsje J. L. Snijders, René S Kahn, Axel R Schulz, Henrik E Mei, Elly M. Hol, Britta Siegmund, Rainer Glauben, Eike J Spruth, Lot D de Witte, Josef Priller
Published in: Nature Neuroscience, Issue 22/1, 2019, Page(s) 78-90, ISSN 1097-6256
DOI: 10.1038/s41593-018-0290-2

Circulating endothelial cells as biomarker for cardiovascular diseases

Author(s): Maura Farinacci, Thomas Krahn, Wilfried Dinh, Hans-Dieter Volk, Hans-Dirk Düngen, Josephine Wagner, Timo Konen, Oliver von Ahsen
Published in: Research and Practice in Thrombosis and Haemostasis, Issue 3/1, 2019, Page(s) 49-58, ISSN 2475-0379
DOI: 10.1002/rth2.12158

Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells

Author(s): Behnam Sadeghi, Gianluca Moretti, Fabian Arnberg, Erik Samén, Bita Kohein, Rusan Catar, Julian Kamhieh-Milz, Sven Geissler, Guido Moll, Staffan Holmin, Olle Ringdén
Published in: Frontiers in Immunology, Issue 10, 2019, ISSN 1664-3224
DOI: 10.3389/fimmu.2019.02685

Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies

Author(s): Guido Moll *, Martin J. Hoogduijn and James A. Ankrum
Published in: Frontiers in Immunology, 2020, ISSN 1664-3224
DOI: 10.3389/fimmu.2020.00243

Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product

Author(s): Guido Moll, Norman Drzeniek, Julian Kamhieh‐Milz, Sven Geissler, Petra Reinke
Published in: British Journal of Haematology, 2020, ISSN 0007-1048
DOI: 10.1111/bjh.16389

Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional Properties

Author(s): Anastazja Andrzejewska, Rusan Catar, Janosch Schoon, Taimoor Hasan Qazi, Frauke Andrea Sass, Dorit Jacobi, Antje Blankenstein, Simon Reinke, David Krüger, Mathias Streitz, Stephan Schlickeiser, Sarina Richter, Naima Souidi, Christien Beez, Julian Kamhieh-Milz, Ulrike Krüger, Tomasz Zemojtel, Karsten Jürchott, Dirk Strunk, Petra Reinke, Georg Duda, Guido Moll, Sven Geissler
Published in: Frontiers in Immunology, Issue 10, 2019, ISSN 1664-3224
DOI: 10.3389/fimmu.2019.02474